Short Acting Beta 2 Agonist

DRUG2 trials

Sponsors

GlaxoSmithKline, Assiut University

Conditions

AsthmaBronchial Asthma

Phase 4

Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year

CompletedNCT02889809

GlaxoSmithKlineAsthma

Start: 2017-07-10End: 2021-06-04Updated: 2024-01-17

Unknown Phase

Impact of Comorbidities, Some Biomarkers, Micro RNA in Childhood Asthma Phenotypes

Not yet recruitingNCT07230912

Assiut UniversityBronchial Asthma

Start: 2025-12-30End: 2027-02-28Target: 82Updated: 2025-11-17

Related Papers

A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma

Pediatric Pulmonology2023-09-202 citations